Dolby Laboratories reported first quarter fiscal year 2024 financial results with a total revenue of $315.6 million and GAAP net income of $67.0 million, or $0.69 per diluted share. On a non-GAAP basis, net income was $98.6 million, or $1.01 per diluted share.
Total revenue was $315.6 million, compared to $334.9 million for the first quarter of fiscal 2023.
GAAP net income was $67.0 million, or $0.69 per diluted share, compared to GAAP net income of $79.4 million, or $0.82 per diluted share, for the first quarter of fiscal 2023.
Non-GAAP net income was $98.6 million, or $1.01 per diluted share, compared to $107.4 million, or $1.11 per diluted share, for the first quarter of fiscal 2023.
Dolby repurchased 968 thousand shares of its common stock and ended the quarter with approximately $132 million of stock repurchase authorization available going forward.
Dolby provided estimates for its second quarter and full year of fiscal 2024. Total revenue for Q2 is estimated to range from $345 million to $375 million and is expected to be roughly $1.30 billion for the full year. Diluted earnings per share is anticipated to range from $0.82 to $0.97 on a GAAP basis and from $1.14 to $1.29 on a non-GAAP basis for Q2. For the full year, diluted earnings per share is anticipated to range from $2.30 to $2.45 on a GAAP basis and from $3.60 to $3.75 on a non-GAAP basis.
Visualization of income flow from segment revenue to net income